您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Galidesivir
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Galidesivir
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Galidesivir图片
CAS NO:249503-25-1
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议
50mg电议

产品名称
BCX4430
Immucillin-A
产品介绍
Galidesivir (BCX4430),一种腺苷类似物和直接作用的抗病毒药物,能破坏病毒 RNA 依赖的 RNA 聚合酶(RdRp)活性。Galidesivir 在体外对多种 RNA 病毒病原体具有活性,包括丝状病毒和新兴的感染因子,如 MERS-CoV、SARS-CoV 和 SARS-CoV-2。Galidesivir 对一些负义 RNA 病毒的 EC50在 ~3 到 ~68 μM。
生物活性

Galidesivir (BCX4430), an adenosine analog and a direct-acting antiviral agent, disrupts viralRNA-dependent RNA polymerase (RdRp)activity. Galidesivir is active in vitro against many RNA viral pathogens, including the filoviruses and emerging infectious agents such as MERS-CoV,SARS-CoV, and SARS-CoV-2. Galidesivir inhibits some negative-sense RNA viruses with EC50s ranging from ~3 to ~68 μM[1][2][3].

IC50& Target

RdRp

体外研究
(In Vitro)

Cellular kinases phosphorylate Galidesivir (BCX4430) to a triphosphate that mimics ATP; viral RNA polymerases incorporate the drug's monophosphate nucleotide into the growing RNA chain, causing premature chain termination[1].
Galidesivir effectively inhibits the infection of Vero cells with YFV. The EC50 determined by the neutral red uptake assay is 8.3 μg/ml (24.5 μM)[3].

体内研究
(In Vivo)

Galidesivir (BCX4430) is active after intramuscular, intraperitoneal, and oral administration in a variety of experimental infections. In nonclinical studies involving lethal infections with Ebola virus, Marburg virus, Rift Valley fever virus, and Yellow Fever virus, Galidesivir has demonstrated pronounced efficacy[1].
Galidesivir (4 mg/kg; i.p.; twice daily for 7 days) is effectively in a hamster model of yellow fever (YF)[4].

Animal Model:Female Syrian golden hamsters (hamsters infected with YF virus)[4]
Dosage:4 mg/kg of body weight
Administration:I.p.; twice daily for 7 days
Result:Significantly improved the survival of hamsters infected with YFV.
Clinical Trial
分子量

265.27

性状

Solid

Formula

C11H15N5O3

CAS 号

249503-25-1

中文名称

加利司韦;加利地韦

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder-20°C3 years
4°C2 years
In solvent-80°C6 months
-20°C1 month
溶解性数据
In Vitro: 

H2O : 1.53 mg/mL(5.77 mM;Need ultrasonic and warming)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM3.7697 mL18.8487 mL37.6974 mL
5 mM0.7539 mL3.7697 mL7.5395 mL
10 mM---------
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。